## Abstract ## Objective In addition to releasing proteins and mediators, cells also release membrane vesicles (exosomes and apoptotic blebs) into the extracellular environment. Apoptotic blebs contain multiple autoantigens, but few data are available concerning the protein content of exosomes. Ex
Association of hepatitis C virus envelope proteins with exosomes
β Scribed by Francesca Masciopinto; Cinzia Giovani; Susanna Campagnoli; Luisa Galli-Stampino; Piero Colombatto; Maurizia Brunetto; T. S. Benedict Yen; Michael Houghton; Piero Pileri; Sergio Abrignani
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 213 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Hepatitis C virus encodes two envelope glycoproteins, E1 and E2, that are released from a polyprotein precursor after cleavage by host signal peptidase(s). These proteins contain a large __N__βterminal ectodomain and a __C__βterminal transmembrane domain, and they assemble as a noncoval
A series of 54 synthetic peptides, 15-20 residues ease is usually asymptomatic in the early stages but often progresses to a chronic infection and can result long, that represented selected parts of the structural proteins of hepatitis C virus (HCV) were in hepatocellular carcinoma [Hopf et al., 199
## Abstract An enzyme immunoassay (EIA) was developed for the determination of antibodies against the βputativeβ core protein of hepatitis C virus (HCV). Antigens used were recombinant fragments (amino acids 6β77 or 6β143) of the HCV core protein, produced in __Escherichia coli__ with truncated hep
Antibody responses to the hepatitis C virus (HCV) envelope proteins E l and E2 were analyzed using two original assays in sera from 86 patients in different stages of disease. A Western blot assay and an immunofluorescence assay (IFA) were developed using envelope proteins produced, respectively, in
The significance of circulating antibody to hepatitis C HCV E1 corresponds to the pestiviral gp33/gp25 envevirus (HCV) envelope glycoprotein 2 (E2)/nonstructural lope glycoprotein and the flaviviral envelope protein protein 1 (NS1) glycoprotein was studied in 83 patients (M/E), whereas E2/NS1 corres